HLA-B*1501 & B2M Product List
You Have Viewed 0 Of 0 Results
Clinical Drug Information
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| AL-002 | AL-002a; AL-002-a; AL-002 | Phase 2 Clinical | Abbvie Inc, Alector Inc | Alzheimer Disease | Details |
| Iluzanebart | VGL-101; VGL 101 | Phase 2 Clinical | Amgen Inc | Posterior Leukoencephalopathy Syndrome; Nerve Degeneration | Details |
| DNL-919 | DNL-919; TAK-920 | Phase 1 Clinical | Denali Therapeutics Inc | Alzheimer Disease | Details |
| VG-3927 | VG-3927 | Phase 1 Clinical | Vigil Neuroscience Inc | Alzheimer Disease | Details |